Cargrilintide 10mg*10 vials

Research-Grade Amylin Analog for Glucose Regulation Studies

Overview: Cagrilintide, an advanced synthetic analog of amylin, is engineered for research professionals focusing on metabolic disorders and glucose homeostasis. This peptide is pivotal for studying the intricate balance of blood glucose levels and the physiological mechanisms of satiety, offering promising insights into diabetes and obesity management through amylin's complementary action to insulin.

Product Specifications:

• Purity: >99% (HPLC verified)
• Formulation: Freeze-dried powder suitable for reconstitution
• Molecular Formula: C194H312N54O59S2
• Molecular Weight: Approximately 4500 g/mol
• CAS Number: 1415456-99-3
• PubChem CID: 167312356

Research Applications:

Utilized in diverse preclinical settings, Cagrilintide aids in:

• Elucidating amylin's role in blood glucose stabilization postprandially
• Investigating the complex interplay between amylin and insulin in glucose regulation
• Exploring therapeutic potentials in synergistic treatments for enhanced metabolic control
• Assessing the impact of amylin analogs on obesity and diabetes phenotypes in experimental models

Features:

• Targeted Amylin Mimic: Cagrilintide closely replicates human amylin's function, providing a precise tool for dissecting its role alongside insulin in maintaining glucose levels.
• Indispensable for Metabolic Disorder Research: Facilitates in-depth analysis of appetite regulation and glucose homeostasis, critical for understanding and combating obesity and diabetes.
• Guaranteed Quality: Every batch is meticulously tested to ensure the highest purity and consistency, enabling reliable and reproducible research outcomes.